P. Emery

1.1k citations

60 papers · 680 indexed · h-index 15

Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies 34
- Systemic Lupus Erythematosus Research 18
- Spondyloarthritis Studies and Treatments 7
Hematology top 10%
- Autoimmune and Inflammatory Disorders Research 4
Immunology
- Immunodeficiency and Autoimmune Disorders 4
Genetics
- Chronic Lymphocytic Leukemia Research 7
Pathology and Forensic Medicine
- Systemic Sclerosis and Related Diseases 4
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 14

Co-authors: Andrew Gough Aarnoud Huissoon Phil Perkins Richard J. Reece R Holder J Devlin J. S. Smolen Caroline Gordon
Cited by: Rheumatology Hematology Immunology
Journals: Annals of the Rheumatic Diseases (14 papers)Lara D. Veeken (8 papers)Value in Health (3 papers)
Partner nations: United Kingdom Denmark United States

In The Last Decade

P. Emery

57 papers receiving 650 citations

Peers

Countries citing papers authored by P. Emery

Since Specialization

Citations

This map shows the geographic impact of P. Emery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Emery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Emery more than expected).

Fields of papers citing papers by P. Emery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Emery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Emery. The network helps show where P. Emery may publish in the future.

Co-authorship network

The 25 scholars most cited alongside P. Emery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P. Emery Line = papers co-authored together P. Emery links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	OP0184 A TREATMENT STRATEGY COMBINING TNF-INHIBITOR, METHOTREXATE AND STEROIDS IS NOT SUPERIOR TO METHOTREXATE AND STEROIDS IN EARLY PSORIATIC ARTHRITIS: RESULTS FROM THE GOLMEPSA RANDOMISED, DOUBLE-BLIND CLINICAL TRIAL Annals of the Rheumatic Diseases ·Gabriele De Marco,E. Hensor,Philip Helliwell,Shahnaz Sultan,Suraiya Dubash,Xabier Michelena,Laura C. Coates,Ai Lyn Tan,P. Emery,Dennis McGonagle,Feiyu Lu	2024	1
2	Preliminary Results of a Double-Blind Randomised Trial of Rituximab Anti-B-Cell Therapy in Patients with Primary Sjogrens Syndrome White Rose Research Online (University of Leeds, The University of Sheffield, University of York) ·Simon Bowman,Colin Everett,Stefano Bombardieri,Robert Busch,P. Emery,Lara Arjan,Nanping Yue,Costantino Pitzalis,明典江頭,Luke Dawson,朱昳晨,Nurhan Sutcliffe,Wan‐Fai Ng,Philipp Batz,Guerino Pagano,Linda Sharples,Catherine Reynolds,Sue Pavitt	2015	12
3	Effect of Anti-Cyclic Citrullinated Peptide 2 Immunoglobulin M Serostatus on Efficacy Outcomes Following Treatment with Abatacept Plus Methotrexate Data Archiving and Networked Services (DANS) ·T. Huizinga,Seán Connolly,Alyssa Johnsen,Jun Zhu,D E Furst,México UNINI,Gerd R Burmester,Bernard Combe,Shradha Shelar,Leendert A. Trouw,René E. M. Toes,P. Emery	2015	1
4	The Impact on Anti-Citrullinated Protein Antibody Isotypes and Epitope Fine Specificity in Patients with Early RA Treated with Abatacept and Methotrexate. Data Archiving and Networked Services (DANS) ·T. Huizinga,Seán Connolly,D E Furst,México UNINI,Gerd R Burmester,Bernard Combe,Chetan S. Karyekar,Jose Alfonso Sanchez Villegas,Leendert A. Trouw,René E. M. Toes,P. Emery	2014	4
5	Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial (vol 381, pg 1541, 2013) The Lancet ·Cem Gabay,P. Emery,Ronald van Vollenhoven	2013	13
6	EVALUATION OF EFFICACY AND SAFETY OF SECUKINUMAB IN THE TREATMENT OF PATIENTS WITH MODERATE-TO-SEVERE ANKYLOSING SPONDYLITIS Lara D. Veeken ·P. Emery,Dominique Baeten,Joachim Sieper,Colin Bayne-Jardine,Désirée van der Heijde,Iain B. McInnes,Jacob M. van Laar,R. Landewé,B P Wordsworth,J. Wollenhaupt,三崎直人,Francisco Esquivias Ferriz,A. Bertolino,A. Wright,Wolfgang Hueber	2012	6
7	Quantitative MRI measurements of the Achilles tendon in spondyloarthritis using ultrashort echo times British Journal of Radiology ·Richard Hodgson,Hind A. Ghanem,Andrew J. Grainger,Philip O’Connor,Dennis McGonagle,Philip Helliwell,P. Emery,Matthew D. Robson	2012	10
8	Efficacy and Safety of Certolizumab Pegol in a Broad Population of Patients with Active Rheumatoid Arthritis: Week 28 Results From a Phase IIIb Randomized Controlled Study Data Archiving and Networked Services (DANS) ·M. Weinblatt,R Fleischmann,Ronald van Vollenhoven,P. Emery,T. Huizinga,矢嶋祥子,Christin Wenzl,Benjamin Duncan,O. Davies,Maxime Dougados	2011	2
9	Assessment of inflammation and damage by MRI in established RA patients with Methotrexate inadequate response receiving Golimumab: Results of the GO-FORWARD trial Annals of the Rheumatic Diseases ·Philip G. Conaghan,P. Emery,Mikkel Østergaard,Ed Keystone,Mark C. Genovese,Lars Klareskog,W. Xu,E. C. Hsia,Mahboob U. Rahman	2011	2
10	Rate of Anti-Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor Seroconversion in Patients with Undifferentiated Arthritis or Early Rheumatoid Arthritis Treated with Abatacept. Data Archiving and Networked Services (DANS) ·T. Huizinga,P. Emery,René Westhovens,Manuela Le Bars,Corine Gaillez,Coralie Poncet,Ayanbola Elegbe,Josef S Smolen	2011	2
11	GOLIMUMAB AND RADIOGRAPHIC PROGRESSION IN RHEUMATOID ARTHRITIS: RESULTS OF GO-BEFORE AND GO-FORWARD STUDIES Lara D. Veeken ·P. Emery,R. Fleischmann,Désirée van der Heijde,Edward Keystone,Mark C. Genovese,Philip G. Conaghan,E. C. Hsia,W. Xu,Anna Baratelle,Anna Beutler,Mahboob U. Rahman,Shaokai Hou	2011	1
12	THE EFFICACY OF CERTOLIZUMAB PEGOL ADDED TO METHOTREXATE IS SUSTAINED OVER 2 YEARS IN THE TREATMENT OF RHEUMATOID ARTHRITIS Lara D. Veeken ·E. Keystone,R. Fleischmann,J S Smolen,Vibeke Strand,Robert Landewé,Bernard Combe,Philip J. Mease,AM Awojide,Niti Goel,D. van der Heijde,P. Emery	2010	1
13	A randomized controlled trial of infliximab shows clinical and MRI efficacy in HLA B27 positive very early ankylosing spondylitis Clinical and Experimental Rheumatology ·佳子新谷,Helen Keen,Laura C. Coates,Patrick J. O’Connor,U. Michajłow,Alexander Fraser,Lorna Cawkwell,D. Mcgonagle,P. Emery	2008	11
14	Golimumab, a new human Anti-TNF-alpha monoclonal antibody, administered subcutaneously everv 4 weeks in methotrexate-naive patients with active rheumatoid arthritis: A randomized, double-blind, placebo-controlled, GO-BEFORE study DIAL (Catholic University of Leuven) ·R Fleischmann,Patrick Durez,P. Emery,Larry W. Moreland,E. C. Hsia,Ingrid Strusberg,João Ferreira Dias,Eric Amante,Melvin Churchill,K Yamanaka,Bernardo A. Pons‐Estel,W. Xu,Mahboob U. Rahman	2008	4
15	Preliminary efficacy results of rituximab retreatment in patients with active rheumatoid arthritis Queensland's institutional digital repository (The University of Queensland) ·R Fleischmann,Karel Pavelká,Jenyffer Bezerra Cintra,E. Martín‐Mola,S Ganjour,Peter Nash,P. Emery,장롱이,Hongxing Chen,Dong Ri Shan,Киселева Валерия Борисовна	2005	7
16	Autologous stem cell transplantation in rheumatoid arthritis eCite Digital Repository (University of Tasmania) ·John A. Snowden,John J. Moore,Rincón Víctor P,Paul Cannell,Jacob M. van Laar,Sarah Bingham,Richard K. Burt,P. Emery,Robyn Asleson,Teppei Niino,RM Lowenthal,Patrick Durez,A Tyndall	2001	3
17	Combination therapy with a TNF antagonist and a CD4 monoclonal antibody in rheumatoid arthritis. A pilot study. Oxford University Research Archive (ORA) (University of Oxford) ·Ann W Morgan,G Hale,Carl W. Hauge,Stephen J. Richards,Herman Waldmann,P. Emery,John D. Isaacs	1997	7
18	EVIDENCE OF OMEPRAZOLE-INDUCED SMALL BOWEL BACTERIAL OVERGROWTH IN PATIENTS WITH SCLERODERMA Lara D. Veeken ·Andrew Gough,David Andrews,P. A. Bacon,P. Emery	1995	22
19	Liver disease in twins with Felty's syndrome. Annals of the Rheumatic Diseases ·Robert J. Moots,Elwyn Elias,ASLAN DİLAVER,M Salmon,P. Emery	1994	4
20	THE HLA CLASS II ASSOCIATIONS OF RHEUMATOID-ARTHRITIS CONFER SEVERITY NOT SUSCEPTIBILITY Oxford University Research Archive (ORA) (University of Oxford) ·Andrew Gough,Jeff Faint,P Wordsworth,M Salmon,P. Emery	1992	2

About P. Emery

P. Emery is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging, Immunology, Genetics and Hematology, having authored 60 papers that have together received 680 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (34 papers), Systemic Lupus Erythematosus Research (18 papers), Monoclonal and Polyclonal Antibodies Research (14 papers), Chronic Lymphocytic Leukemia Research (7 papers), Spondyloarthritis Studies and Treatments (7 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Systemic Sclerosis and Related Diseases (4 papers). The work is most often cited by research in Rheumatology (432 citations), Hematology (119 citations), Immunology (170 citations), Genetics (57 citations) and Pathology and Forensic Medicine (85 citations). P. Emery has collaborated with scholars based in United Kingdom, Denmark and United States. Frequent co-authors include Andrew Gough, Aarnoud Huissoon, Phil Perkins, Richard J. Reece, R Holder, J Devlin, J. S. Smolen, Caroline Gordon, P. A. Bacon and C. Richardson. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Value in Health, Clinical and Experimental Rheumatology and Lupus.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact